Henderson, DC, Cagliero, E, Copeland, PM, Louie, PM, Borba, CP, Fan, X, et al.
Elevated haemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry
2007; 68: 533–41.
Jin, H, Meyer, JM, Jeste, DV. Phenomenology of and risk factors for new onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry
2002; 14: 59–64.
Leslie, DL, Rosenheck, RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry
2004; 161: 1709–11.
Nihalani, ND, Tu, X, Lamberti, JS, Olson, D, Olivares, T, Costea, GO, et al.
Diabetic ketoacidosis among patients receiving Clozapine: a case series and review of socio-demographic risk factors. Ann Clin Psychiatry
2007; 19: 105–12.
Koller, E, Schneider, B, Bennett, K, Dubitsky, G.
Clozapine-associated diabetes. Am J Med
2011; 111: 716–23.